Filing status
- Accounts due
- 30 September 2027
- Last accounts
- 31 December 2025
- Conf. stmt due
- 18 February 2027
- Last conf. stmt
- 4 February 2026
Tentamus Pharma (UK) Limited
- Incorporated
- 4 February 2004 (22 years)
- Previously known as
- Food and Drug Analytical Services Limited (until 29 March 2021)
- Industry
- Technical testing and analysis (71200)
- Directors
- Nicola Giovanni Berruti
- Owned by
- Accounts type
- Small
- Region
- East Midlands
- Address
- Orbis 3 Riverside RoadPride ParkDerbyDE24 8HY
Charges
- Total
- 5
- Outstanding
- 1
- Part satisfied
- 0
- Satisfied
- 4
Officers 1 active
Officer details are public data from the Companies House register.
Berruti, Nicola Giovanni
Director · Appointed 1 July 2025
Italian
Born December 1970 (55)
Officer history (12 former)
1 July 2025
1 July 2025
Appointed Berruti, Nicola Giovanni as Director
20 January 2023
26 July 2022
6 May 2022
4 April 2016
4 April 2016
4 April 2016
30 April 2015
30 April 2015
27 April 2015
23 August 2011
18 August 2011
Resigned Harper, Paul Bernard, Dr as Director
31 May 2008
10 November 2004
10 November 2004
Appointed Harper, Paul Bernard, Dr as Director
10 November 2004
1 November 2004
23 August 2004
26 July 2004
26 July 2004
17 February 2004
17 February 2004
4 February 2004
4 February 2004
Ownership 1 active
People and entities with significant control, from the Companies House PSC register
Corporate entity · Notified 6 April 2016
Owns 75–100% of shares
Holds 75–100% of voting rights
Right to appoint and remove directors
Limited Company
Reg. no. 09357227
Group structure 9 companies
Ownership group derived from the Companies House PSC register
Blutest Laboratories Limited Owns 75–100% of shares
Helvic Limited Owns 75–100% of shares
Minerva Scientific Limited Owns 75–100% of shares
One Scientific Limited Owns 50–75% of shares
Precision Analysis (North West) Limited Owns 75–100% of shares
Southern Microbiological Services Limited Owns 75–100% of shares
Tentamus Pharma (UK) Limited This company Owns 75–100% of shares
Tentamus QTS Analytical Limited Owns 75–100% of shares
Financials
Figures from 2024 accounts. Newer accounts, made up to 31 December 2025, are filed but not read yet. See them on Companies House
- Net Assets
- £1,902,601
- Cash
- £27,546
- Profit
- £76,545
- Debt Ratio
- 33%
- Current Ratio
- 1.1x
- Return on Equity
- 4%
Trend
Net Assets
Balance sheet detail
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|
| Fixed Assets | £1,801,880 | £1,788,816 | £1,702,561 | £1,360,488 | £250,154 | £68,017 |
| Current Assets | £1,043,824 | £954,522 | £1,368,185 | £825,987 | £580,810 | £517,144 |
| Debtors | £813,857 | £742,370 | £1,053,951 | £659,025 | £450,615 | £298,748 |
| Cash | £27,546 | £6,942 | £161,086 | £32,011 | £68,945 | £158,771 |
| Creditors (< 1 year) | £937,807 | £901,494 | £1,302,210 | £797,961 | £318,280 | £210,934 |
| Creditors (> 1 year) | £5,296 | £15,788 | £25,000 | £35,000 | £708,617 | £218,089 |
| Net Current Assets | £106,017 | £53,028 | £65,975 | £28,026 | £262,530 | £306,210 |
| Net Assets | £1,902,601 | £1,826,056 | £1,743,536 | £1,353,514 | (£195,933) | £156,138 |
| Shareholder Funds | £1,902,601 | £1,826,056 | £1,743,536 | £1,353,514 | (£195,933) | £156,138 |
Filings
Filing history not loaded yet. See it on Companies House
Other companies in this industry
Liverpool
London
Norwich
Cheltenham
By trade and location
Need accounts figures, ownership or websites for thousands of companies? Bulk data & API →